Qtron Investments LLC Horizon Therapeutics Public LTD CO Transaction History

Qtron Investments LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $138,381 - $252,408	2,218 New	2,218 $252,000
Q4 2021 Feb 16, 2022	SELL	$98.56 - $119.91 $87,028 - $105,880	-883 Reduced 9.91%	8,030 $865,000
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $416,444 - $500,086	4,531 Added 103.4%	8,913 $976,000
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $117,370 - $156,014	-1,634 Reduced 27.16%	4,382 $403,000
Q3 2020 Nov 12, 2020	BUY	$55.23 - $79.93 $65,723 - $95,116	1,190 Added 24.66%	6,016 $467,000
Q2 2020 Aug 13, 2020	SELL	$30.2 - $56.98 $60,067 - $113,333	-1,989 Reduced 29.19%	4,826 $268,000
Q1 2020 May 14, 2020	SELL	$24.87 - $38.56 $135,765 - $210,499	-5,459 Reduced 44.48%	6,815 $202,000
Q3 2019 Nov 12, 2019	BUY	$23.0 - $27.97 $282,302 - $343,303	12,274 New	12,274 $334,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Qtron Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Qtron Investments LLC with notifications on news.